Effects of clomiphene citrate plus estradiol or progesterone on endometrial ultrastructure: An RCT

سال انتشار: 1398
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 160

فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJRM-18-3_006

تاریخ نمایه سازی: 12 فروردین 1400

چکیده مقاله:

Background: Pinopods concentrations in endometrial surface is a marker of implantation. estradiol valerate (EV) was used for change the adverse effects of Clomiphene Citrate (CC) on the endometrium. Endometrial morphology was less examined in this fields. Objective (s): To assess whether there is a significant difference in endometrial pinopods concentrations and other parameters after adding estradiol valerate (EV) and progesterone to higher doses of clomiphene citrate (CC). Study design: In this prospective randomized clinical trial, a total of 30 women, who did not respond to 100 mg CC from February 2016 until June 2016 were evaluated. They received 150 mg CC alone or CC with EV or CC plus progesterone. On day 21 of the menstrual cycle, endometrial biopsy and a blood sampling and scanning by electron microscopy were performed. Results: On day 21 of the menstrual cycle there was no significant difference regarding pinopods concentrations (P=0.641) and serum estrogen levels (P=0.276) between groups. Serum progesterone levels on day 21 of the menstrual cycle among patients treated with CC, was higher than the other two groups (P=0.007). Conclusions: The addition of EV and progesterone to higher dosages of CC, did not changes the pinopods concentration and serum estrogen levels on day 21 of the menstrual cycle. It can be concluded that the anti- estrogenic effects of CC just appear on the endometrium. In this study, there were higher levels of serum progesterone on day 21 of the menstrual cycles in the CC alone compared to other two groups.

نویسندگان

Robabeh Taheripanah

Infertility and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Maryam Kabir-salmani

Department of Biomaterials and Tissue Engineering, Stem Cell Division, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran.

Masoomeh Favayedi

Infertility and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Marzieh Zamaniyan

Diabetes Research Center, Mazandaran University of Medical Sciences, Sari, Iran.

Narges Malih

Social Determinants of Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Anahita Taheripanah

Department of Molecular and Cellular Sciences, Faculty of Advanced Sciences and Technology Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iran.

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • 1. Seyedoshohadaei F, Zandvakily F, Shahgeibi S. Comparison of the effectiveness ...
  • 2. Gadipudi A, Dasari P, Sagili H. Tamoxifen for ovulation induction ...
  • 3. Mouhayar Y, Sharara FI. Modern management of thin lining. Middle ...
  • 4. Madero S, Rodriguez A, Vassena R, Vernaeve V. Endometrial preparation: ...
  • 5. Kelleher AM, Burns GW, Behura S, Wu G, Spencer TE. ...
  • 6. Steiner AZ, Terplan M, Paulson RJ. Comparison of tamoxifen and ...
  • 7. El-Gharib MN, Mahfouz AE, Farahat MA. Comparison of letrozole versus ...
  • 8. Achache H, Revel A. Endometrial receptivity markers, the journey to ...
  • 9. Bao SH, Le Sheng SL, Peng YF, De Lin QD. ...
  • 10. Davar R, Javedani M, Fallahzadeh MH. Metformin-letrozole in comparison with ...
  • 11. Davar R, Aflatoonian A. The effect of letrozole in induction ...
  • 12. Creus M, Ordi J, Fábregues F, Casamitjana R, Carmona F, ...
  • 13. Gerli S, Gholami H, Manna C, Di Frega AS, Vitiello ...
  • 14. Unfer V, Casini ML, Costabile L, Mignosa M, Gerli S, ...
  • 15. Check JH, Dietterich C, Lurie D. The effect of consecutive ...
  • 16. Yagel S, Ben-Chetrit A, Anteby E, Zacut D, Hochner-Celnikier D, ...
  • 17. Shimoya K, Tomiyama T, Hashimoto K, Moriyama A, Kawamoto A, ...
  • 18. Harira M. Use of Letrozole versus clomiphene-estradiol for treating infertile ...
  • 19. Palomino WA, Fuentes A, González RR, Gabler F, Boric MA, ...
  • 20. Massai MR, de Ziegler D, Lesobre V, Bergeron C, Frydman ...
  • 21. Ganesh A, Chauhan N, Das S, Chakravarty B, Chaudhury K. ...
  • 22. Cortínez A, De Carvalho I, Vantman D, Gabler F, Iñiguez ...
  • 23. Usadi RS, Murray MJ, Bagnell RC, Fritz MA, Kowalik AI, ...
  • 24. Omran E, El-Sharkawy M, El-Mazny A, Hammam M, Ramadan W, ...
  • 25. Seyedoshohadaei F, Tangestani L, Zandvakili F, Rashadmanesh N. Comparison of ...
  • 26. Nejatbakhsh R, Kabir-Salmani M, Dimitriadis E, Hosseini A, Taheripanah R, ...
  • 1. Seyedoshohadaei F, Zandvakily F, Shahgeibi S. Comparison of the ...
  • 2. Gadipudi A, Dasari P, Sagili H. Tamoxifen for ovulation ...
  • 3. Mouhayar Y, Sharara FI. Modern management of thin lining. ...
  • 4. Madero S, Rodriguez A, Vassena R, Vernaeve V. Endometrial ...
  • 5. Kelleher AM, Burns GW, Behura S, Wu G, Spencer ...
  • 6. Steiner AZ, Terplan M, Paulson RJ. Comparison of tamoxifen ...
  • نمایش کامل مراجع